Fundraising Fox
🦊/People
Sign in

Cain McClary

Investor

Advisor at 8VC · Managing Partner at KdT Ventures · Board director at Debut Biotechnology · Board director at Elegen · Board director at Checkerspot

Austin, Texas

Writes $500K – $3M checks · typically $850K

Find your path to Cain

1,293 people in our graph share verified history with Cain — schools, employers, funds. One of them is your warm intro.

Deep NisharunlockedCain: together at Stanford University (2015–2017)
×3Cain: together at Stanford University
×3Cain: together at 8VC
Cain: together at Brown University

About

Physician-scientist turned venture capitalist who trained and practiced pathology at Stanford, bringing diagnostic and clinical expertise plus a multi-dimensional, creative (Dad, DJ, Doctor, Outdoor Enthusiast, Type-A) viewpoint to medical startups.

Contact· self-published, not guessed

Invests in

AgTechAI & Machine LearningBiotechFoodTechHealthtechNew Materials

Board director at Debut Biotechnology

Intro paths

→

In turn, Cain can intro founders to Debut Biotechnology's investors below.

Debut Biotechnology's investors · 6

Bold Capital PartnersSanta MonicaCantos VenturesSan Francisco · $400K – $1.5M checks · since 2020Cavallo VenturesSan FranciscoDICsince 2023FTW VenturesSan Francisco · $100K – $500K checks · since 2020KdT VenturesAustin · $500K – $3M checks · since 2019

Co-founders at Debut Biotechnology

JBJoshua Britton
Joshua BrittonExecutive Officer, Director

Board director at Elegen

Intro paths

→

In turn, Cain can intro founders to Elegen's investors below.

Elegen's investors · 9

ACVC PartnersSilicon Valley · since 2024AME Cloud VenturesPalo Alto · $1M – $10M checks · since 2024Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024In-Q-TelTysons · $100K – $2.5M checks · since 2024KdT VenturesAustin · $500K – $3M checks · since 2024National Institutes of Health (NIH)since 2020Raptor GroupMiami Beach · since 2024Triatomic CapitalPalo Alto · $100K – $1M checks · since 2024

Co-founders at Elegen

MHMatthew Hill
Matthew HillExecutive Officer, Director

Board director at Checkerspot

Intro paths

→

In turn, Cain can intro founders to Checkerspot's investors below.

Checkerspot's investors · 6

Baruch Future VenturesSan Francisco · $100K – $1M checksBreakout VenturesSan Francisco · $500K – $6M checks · since 2022Builders VCSan FranciscoCavallo VenturesSan FranciscoKdT VenturesAustin · $500K – $3M checks · since 2020Refactor CapitalBurlingame · $1M – $2M checks

Co-founders at Checkerspot

SF
Scott FranklinExecutive Officer, Director
CDCharles Dimmler
Charles DimmlerExecutive Officer, Director

Experience

  1. KdT VenturesFounder and Managing Partnercurrent2017 — present
  2. InvestorTrying to Helpcurrent2010 — presentAsheville, NC
  3. 8VCAdvisorcurrent2017 — presentSan Francisco, California
  4. Tulane University School of MedicineClinical Instructor and Visiting Professorcurrent2017 — presentGreater New Orleans Area
  5. Included HealthStaff Physician and Analytics/Data Science Lead2014 — 2017San Francisco Bay Area
  6. Stanford UniversityConsulting Assistant Professor2015 — 2017
  7. Stanford University Medical CenterPathologist2012 — 2015Palo Alto, CA
  8. Howard Hughes Medical InstituteResearch Scholar2010 — 2011Bethesda, MD

Skills & more

Clinical Research62PCR13Molecular Biology27Cell Culture10Lifesciences13Genetics26Oncology10Business Strategy3Business Development9Fundraising2Start-up Ventures3Healthcare Information Technology4
+12 moreResearchBiotechnologyDNABiochemistryImmunologyCancerBioinformaticsImmunohistochemistryGenomicsHealthcare improvementLife SciencesHealthcare

From Cain's professional profile.

Deals · 3

AzitraBoard seat

via KdT Ventures · filed Sep 2020 · $17M raise

Debut BiotechnologyBoard seat

via KdT Ventures · filed Jan 2020 · $2.6M raise

CheckerspotBoard seat

via KdT Ventures · filed May 2018 · $6.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Elegen

Investor

Character BiosciencesElegenTierra Biosciences

Sources: SEC Form D filings · curated public sources.

Colleagues at 8VC

Adrienne Alexander
Operations at 8VC
Aidan Pratt
Founder at Autostep
Alex Kolicich
Investment Team at 8VC
Alex McLane
Investment Team at 8VC
Alex Moore
Investment Team at 8VC
Arthur James
Advisor at 8VC
Arun Gupta
Founder & CEO, Quartet, Accretive, The World Bank, McKinsey at AIF
Asanka Jayasuriya
Portfolio Support at 8VC

Network4

Ketan Yerneni
Principal at KdT Ventures
Mack Healy
Managing Partner at KdT Ventures
Patrick Malone
Partner at KdT Ventures
Phil Grayeski
Managing Partner at KdT Ventures

Investors connected to Cain in public investor directories — a warm-intro map.

Frequently asked questions

Who is Cain McClary?
Physician-scientist turned venture capitalist who trained and practiced pathology at Stanford, bringing diagnostic and clinical expertise plus a multi-dimensional, creative (Dad, DJ, Doctor, Outdoor Enthusiast, Type-A) viewpoint to medical startups.
Where does Cain McClary work?
Cain McClary is Advisor at 8VC and Board director at Debut Biotechnology and Board director at Elegen and Board director at Checkerspot.
What does Cain McClary invest in?
Cain McClary invests in AgTech, AI & Machine Learning, Biotech, FoodTech, Healthtech, New Materials.
What check size does Cain McClary write?
Cain McClary typically writes checks of $500K – $3M.
What boards does Cain McClary sit on?
Cain McClary holds tracked board seats at Azitra, Checkerspot, Debut Biotechnology, Elegen.
What companies has Cain McClary invested in?
Investments tracked here include Character Biosciences, Checkerspot, Elegen, Tierra Biosciences.
Where did Cain McClary go to school?
Cain McClary studied at Brown University (Sc.B., Biochemistry and Molecular Biology); Tulane University School of Medicine (Doctor of Medicine (MD)); Stanford University School of Medicine (Residency, Pathology).

Founder mafias

Same school

Shared employers